Depot Buprenorphine Injection in the Management of Opioid Use Disorder: From Development to Implementation (vol 10, pg 69, 2019)

被引：0
|
作者：
Ling, W.
Shoptaw, S.
Goodman-Meza, D.
机构：
来源：
SUBSTANCE ABUSE AND REHABILITATION | 2020年 / 11卷
关键词：
D O I：
10.2147/SAR.S247083
中图分类号：
R194 [卫生标准、卫生检查、医药管理];
学科分类号：
摘要：
引用
收藏
页码：19 / 20
页数：2
相关论文
共 50 条
  • [1] Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation
    Ling, Walter
    Shoptaw, Steve
    Goodman-Meza, David
    SUBSTANCE ABUSE AND REHABILITATION, 2019, 10 : 69 - 78
  • [2] Clinical applications of buprenorphine depot injection for opioid use disorder
    Allikmets, Silvia
    Vink, Jasper Pieter
    ADDICTION, 2020, 115 (01) : 190 - 190
  • [3] Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA (vol 40, pg 61, 2024)
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (04) : 172 - 172
  • [4] Evaluation of the Effects of a Monthly Buprenorphine Depot Subcutaneous Injection on QT Interval During Treatment for Opioid Use Disorder
    Schmith, Virginia D.
    Curd, Laura
    Lohmer, Lauren R. L.
    Laffont, Celine M.
    Andorn, Anne
    Young, Malcolm A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (03) : 576 - 584
  • [5] Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder - a case report
    Delic, M.
    EUROPEAN PSYCHIATRY, 2024, 67 : S415 - S415
  • [6] eComparison of oral buprenorphine/naloxone, depot buprenorphine and methadone for patients released from custodial settings with opioid use disorder
    Shi, Avelyn
    Naz, Rokshar
    Hanby, Matthew F.
    McKenzie, Cameron R. L.
    Moe, Syed
    Dunlop, Adrian J.
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S164 - S164
  • [7] SUBSTITUTION THERAPY WITH FLEXIBLE-DOSE DEPOT BUPRENORPHINE INJECTION TO TREAT OPIOID USE DISORDER IN THE UNITED KINGDOM: A PHARMACOECONOMIC ASSESSMENT
    Tiberg, R.
    Jensen, R.
    Sanjurjo, V
    Carter, J. A.
    VALUE IN HEALTH, 2017, 20 (09) : A711 - A711
  • [8] Treating Opioid Use Disorder With a Monthly Subcutaneous Buprenorphine Depot Injection: 12-Month Safety, Tolerability, and Efficacy Analysis
    Andorn, Anne C.
    Haight, Barbara R.
    Shinde, Sunita
    Fudala, Paul J.
    Zhao, Yue
    Heidbreder, Christian
    Learned, Susan M.
    Fox, Norma Lynn
    Nadipelli, Vijay R.
    Hassman, David
    Rutrick, Daniel
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2020, 40 (03) : 231 - 239
  • [9] Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
    Blair, Hannah A.
    DRUGS & THERAPY PERSPECTIVES, 2024, 40 (02) : 61 - 71
  • [10] Buprenorphine extended-release injection (Brixadi®) in the management of opioid use disorder: a profile of its use in the USA
    Hannah A. Blair
    Drugs & Therapy Perspectives, 2024, 40 : 61 - 71
12345